BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dawson LF, Valiente E, Donahue EH, Birchenough G, Wren BW. Hypervirulent Clostridium difficile PCR-ribotypes exhibit resistance to widely used disinfectants. PLoS One 2011;6:e25754. [PMID: 22039420 DOI: 10.1371/journal.pone.0025754] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 3.9] [Reference Citation Analysis]
Number Citing Articles
1 Passmore IJ, Letertre MPM, Preston MD, Bianconi I, Harrison MA, Nasher F, Kaur H, Hong HA, Baines SD, Cutting SM, Swann JR, Wren BW, Dawson LF. Para-cresol production by Clostridium difficile affects microbial diversity and membrane integrity of Gram-negative bacteria. PLoS Pathog 2018;14:e1007191. [PMID: 30208103 DOI: 10.1371/journal.ppat.1007191] [Cited by in Crossref: 46] [Cited by in F6Publishing: 37] [Article Influence: 11.5] [Reference Citation Analysis]
2 Ferreira TG, Barbosa TF, Teixeira FL, Ferreira EDO, Duarte RS, Domingues RMCP, de Paula GR. Effect of hospital disinfectants on spores of clinical Brazilian Clostridium difficile strains. Anaerobe 2013;22:121-2. [DOI: 10.1016/j.anaerobe.2013.04.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
3 Pawlowski SW. Clostridium difficile Infection Update for the Hospital-Based Physician. Curr Emerg Hosp Med Rep 2014;2:214-23. [DOI: 10.1007/s40138-014-0053-7] [Reference Citation Analysis]
4 Ghose C, Eugenis I, Edwards AN, Sun X, McBride SM, Ho DD. Immunogenicity and protective efficacy of Clostridium difficile spore proteins. Anaerobe 2016;37:85-95. [PMID: 26688279 DOI: 10.1016/j.anaerobe.2015.12.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
5 Udompijitkul P, Alnoman M, Sarker MR. Inactivation strategy for Clostridium perfringens spores adhered to food contact surfaces. Food Microbiology 2013;34:328-36. [DOI: 10.1016/j.fm.2013.01.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
6 Jones IA, Joshi LT. Biocide Use in the Antimicrobial Era: A Review. Molecules 2021;26:2276. [PMID: 33919993 DOI: 10.3390/molecules26082276] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Barra-Carrasco J, Paredes-Sabja D. Clostridium difficile spores: a major threat to the hospital environment. Future Microbiol. 2014;9:475-486. [PMID: 24810347 DOI: 10.2217/fmb.14.2] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 4.3] [Reference Citation Analysis]
8 Ghose C. Clostridium difficile infection in the twenty-first century. Emerg Microbes Infect. 2013;2:e62. [PMID: 26038491 DOI: 10.1038/emi.2013.62] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 6.6] [Reference Citation Analysis]
9 Fuchs BB, Tharmalingam N, Mylonakis E. Vulnerability of long-term care facility residents to Clostridium difficile infection due to microbiome disruptions. Future Microbiol 2018;13:1537-47. [PMID: 30311778 DOI: 10.2217/fmb-2018-0157] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
10 Lynch M, Walsh TA, Marszalowska I, Webb AE, Mac Aogain M, Rogers TR, Windle H, Kelleher D, O'Connell MJ, Loscher CE. Surface layer proteins from virulent Clostridium difficile ribotypes exhibit signatures of positive selection with consequences for innate immune response. BMC Evol Biol 2017;17:90. [PMID: 28335725 DOI: 10.1186/s12862-017-0937-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
11 McSharry S, Koolman L, Whyte P, Bolton D. Investigation of the Effectiveness of Disinfectants Used in Meat-Processing Facilities to Control Clostridium sporogenes and Clostridioides difficile Spores. Foods 2021;10:1436. [PMID: 34205779 DOI: 10.3390/foods10061436] [Reference Citation Analysis]
12 Moorhead S, Maclean M, Coia JE, MacGregor SJ, Anderson JG. Synergistic efficacy of 405 nm light and chlorinated disinfectants for the enhanced decontamination of Clostridium difficile spores. Anaerobe 2016;37:72-7. [PMID: 26708703 DOI: 10.1016/j.anaerobe.2015.12.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
13 Jones AM, Kuijper EJ, Wilcox MH. Clostridium difficile: a European perspective. J Infect. 2013;66:115-128. [PMID: 23103666 DOI: 10.1016/j.jinf.2012.10.019] [Cited by in Crossref: 85] [Cited by in F6Publishing: 79] [Article Influence: 8.5] [Reference Citation Analysis]
14 Dembek M, Willing SE, Hong HA, Hosseini S, Salgado PS, Cutting SM. Inducible Expression of spo0A as a Universal Tool for Studying Sporulation in Clostridium difficile. Front Microbiol 2017;8:1793. [PMID: 28983286 DOI: 10.3389/fmicb.2017.01793] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
15 Park GW, Cho M, Cates EL, Lee D, Oh BT, Vinjé J, Kim JH. Fluorinated TiO₂ as an ambient light-activated virucidal surface coating material for the control of human norovirus. J Photochem Photobiol B 2014;140:315-20. [PMID: 25222145 DOI: 10.1016/j.jphotobiol.2014.08.009] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
16 Ramana J, Tamanna. dbDiarrhea: The database of pathogen proteins and vaccine antigens from diarrheal pathogens. Infection, Genetics and Evolution 2012;12:1647-51. [DOI: 10.1016/j.meegid.2012.08.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
17 Harrison MA, Faulds-Pain A, Kaur H, Dupuy B, Henriques AO, Martin-Verstraete I, Wren BW, Dawson LF. Clostridioides difficile para-Cresol Production Is Induced by the Precursor para-Hydroxyphenylacetate. J Bacteriol 2020;202:e00282-20. [PMID: 32631945 DOI: 10.1128/JB.00282-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Taggart MG, Snelling WJ, Naughton PJ, La Ragione RM, Dooley JSG, Ternan NG. Biofilm regulation in Clostridioides difficile: Novel systems linked to hypervirulence. PLoS Pathog 2021;17:e1009817. [PMID: 34499698 DOI: 10.1371/journal.ppat.1009817] [Reference Citation Analysis]
19 Elahi M, Nakayama-Imaohji H, Hashimoto M, Tada A, Yamasaki H, Nagao T, Kuwahara T. The Human Gut Microbe Bacteroides thetaiotaomicron Suppresses Toxin Release from Clostridium difficile by Inhibiting Autolysis. Antibiotics (Basel) 2021;10:187. [PMID: 33671889 DOI: 10.3390/antibiotics10020187] [Reference Citation Analysis]
20 Mihaescu A, Augustine AM, Khokhar HT, Zafran M, Masood SSME, Gilca-Blanariu GE, Covic A, Nistor I. Clostridioides difficile Infection in Patients with Chronic Kidney Disease: A Systematic Review. Biomed Res Int 2021;2021:5466656. [PMID: 34557546 DOI: 10.1155/2021/5466656] [Reference Citation Analysis]
21 Anosova NG, Cole LE, Li L, Zhang J, Brown AM, Mundle S, Zhang J, Ray S, Ma F, Garrone P, Bertraminelli N, Kleanthous H, Anderson SF. A Combination of Three Fully Human Toxin A- and Toxin B-Specific Monoclonal Antibodies Protects against Challenge with Highly Virulent Epidemic Strains of Clostridium difficile in the Hamster Model. Clin Vaccine Immunol 2015;22:711-25. [PMID: 25924765 DOI: 10.1128/CVI.00763-14] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 3.1] [Reference Citation Analysis]
22 Dyer C, Hutt LP, Burky R, Joshi LT. Biocide Resistance and Transmission of Clostridium difficile Spores Spiked onto Clinical Surfaces from an American Health Care Facility. Appl Environ Microbiol 2019;85:e01090-19. [PMID: 31300397 DOI: 10.1128/AEM.01090-19] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
23 Chow VCY, Kwong TNY, So EWM, Ho YII, Wong SH, Lai RWM, Chan RCY. Surveillance of antibiotic resistance among common Clostridium difficile ribotypes in Hong Kong. Sci Rep 2017;7:17218. [PMID: 29222426 DOI: 10.1038/s41598-017-17523-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
24 Orozco-Aguilar J, Alfaro-Alarcón A, Acuña-Amador L, Chaves-Olarte E, Rodríguez C, Quesada-Gómez C. In vivo animal models confirm an increased virulence potential and pathogenicity of the NAP1/RT027/ST01 genotype within the Clostridium difficile MLST Clade 2. Gut Pathog 2020;12:45. [PMID: 32983262 DOI: 10.1186/s13099-020-00383-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Hung YP, Ko WC, Chou PH, Chen YH, Lin HJ, Liu YH, Tsai HW, Lee JC, Tsai PJ. Proton-Pump Inhibitor Exposure Aggravates Clostridium difficile-Associated Colitis: Evidence From a Mouse Model. J Infect Dis. 2015;212:654-663. [PMID: 25805751 DOI: 10.1093/infdis/jiv184] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
26 Aronoff DM. Editorial commentary: Host-pathogen interactions in Clostridium difficile infection: it takes two to tango. Clin Infect Dis 2014;58:1401-3. [PMID: 24604896 DOI: 10.1093/cid/ciu141] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
27 Badilla-Lobo A, Rodríguez C. Microbiological features, epidemiology, and clinical presentation of Clostridioidesdifficile strains from MLST Clade 2: A narrative review. Anaerobe 2021;69:102355. [PMID: 33711422 DOI: 10.1016/j.anaerobe.2021.102355] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Pizarro-guajardo M, Chamorro-veloso N, Vidal RM, Paredes-sabja D. New insights for vaccine development against Clostridium difficile infections. Anaerobe 2019;58:73-9. [DOI: 10.1016/j.anaerobe.2019.04.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
29 Zerrouki H, Rebiahi SA, Elhabiri Y, Fatmi A, Baron SA, Pagnier I, Diene SM, Rolain JM. Prevalence and Antimicrobial Resistance of Paeniclostridium sordellii in Hospital Settings. Antibiotics (Basel) 2021;11:38. [PMID: 35052916 DOI: 10.3390/antibiotics11010038] [Reference Citation Analysis]
30 Kirkup BC. Culture-independence for surveillance and epidemiology. Pathogens 2013;2:556-70. [PMID: 25437208 DOI: 10.3390/pathogens2030556] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
31 Swett R, Cisneros GA, Feig AL. Conformational analysis of Clostridium difficile toxin B and its implications for substrate recognition. PLoS One 2012;7:e41518. [PMID: 22844485 DOI: 10.1371/journal.pone.0041518] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
32 Monaghan TM, Seekatz AM, Mullish BH, Moore-Gillon CCER, Dawson LF, Ahmed A, Kao D, Chan WC. Clostridioides difficile: innovations in target discovery and potential for therapeutic success. Expert Opin Ther Targets 2021;:1-15. [PMID: 34793686 DOI: 10.1080/14728222.2021.2008907] [Reference Citation Analysis]
33 Dawson LF, Valiente E, Faulds-Pain A, Donahue EH, Wren BW. Characterisation of Clostridium difficile biofilm formation, a role for Spo0A. PLoS One 2012;7:e50527. [PMID: 23236376 DOI: 10.1371/journal.pone.0050527] [Cited by in Crossref: 93] [Cited by in F6Publishing: 82] [Article Influence: 9.3] [Reference Citation Analysis]
34 Deakin LJ, Clare S, Fagan RP, Dawson LF, Pickard DJ, West MR, Wren BW, Fairweather NF, Dougan G, Lawley TD. The Clostridium difficile spo0A gene is a persistence and transmission factor. Infect Immun. 2012;80:2704-2711. [PMID: 22615253 DOI: 10.1128/iai.00147-12] [Cited by in Crossref: 229] [Cited by in F6Publishing: 160] [Article Influence: 22.9] [Reference Citation Analysis]
35 Dobreva EG, Ivanov IN, Vathcheva-dobrevska RS, Ivanova KI, Asseva GD, Petrov PK, Kantardjiev TV. Advances in molecular surveillance of Clostridium difficile in Bulgaria. Journal of Medical Microbiology 2013;62:1428-34. [DOI: 10.1099/jmm.0.058149-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
36 Joshi LT, Welsch A, Hawkins J, Baillie L. The effect of hospital biocide sodium dichloroisocyanurate on the viability and properties of Clostridium difficile spores. Lett Appl Microbiol 2017;65:199-205. [PMID: 28639362 DOI: 10.1111/lam.12768] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
37 Carlson PE Jr, Kaiser AM, McColm SA, Bauer JM, Young VB, Aronoff DM, Hanna PC. Variation in germination of Clostridium difficile clinical isolates correlates to disease severity. Anaerobe 2015;33:64-70. [PMID: 25681667 DOI: 10.1016/j.anaerobe.2015.02.003] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
38 Buffet-Bataillon S, Tattevin P, Bonnaure-Mallet M, Jolivet-Gougeon A. Emergence of resistance to antibacterial agents: the role of quaternary ammonium compounds--a critical review. Int J Antimicrob Agents 2012;39:381-9. [PMID: 22421329 DOI: 10.1016/j.ijantimicag.2012.01.011] [Cited by in Crossref: 309] [Cited by in F6Publishing: 246] [Article Influence: 30.9] [Reference Citation Analysis]
39 Abt MC, McKenney PT, Pamer EG. Clostridium difficile colitis: pathogenesis and host defence. Nat Rev Microbiol 2016;14:609-20. [PMID: 27573580 DOI: 10.1038/nrmicro.2016.108] [Cited by in Crossref: 227] [Cited by in F6Publishing: 191] [Article Influence: 37.8] [Reference Citation Analysis]
40 . Hygienemaßnahmen bei Clostridioides difficile-Infektion (CDI): Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) beim Robert Koch-Institut. Bundesgesundheitsbl 2019;62:906-23. [DOI: 10.1007/s00103-019-02959-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
41 Lachowicz D, Szulencka G, Obuch-Woszczatyński P, van Belkum A, Pituch H. First Polish outbreak of Clostridium difficile ribotype 027 infections among dialysis patients. Eur J Clin Microbiol Infect Dis 2015;34:63-7. [PMID: 25060801 DOI: 10.1007/s10096-014-2204-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]